| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Active site-inhibited seven: Mechanism of action including signal transduction
|
Petersen, Lars C
|
|
2001
|
38 |
S12 |
p. 39-42
4 p.
|
article
|
| 2 |
Effect of recombinant factor VIIa (NovoSeven®) on thrombocytopenia-like conditions in vitro
|
Kjalke, Marianne
|
|
2001
|
38 |
S12 |
p. 15-20
6 p.
|
article
|
| 3 |
Inhibitor treatment: State of the art
|
Shapiro, Amy
|
|
2001
|
38 |
S12 |
p. 26-34
9 p.
|
article
|
| 4 |
Recombinant factor VIIa (NovoSeven®) and the safety of treatment
|
Roberts, Harold R
|
|
2001
|
38 |
S12 |
p. 48-50
3 p.
|
article
|
| 5 |
Recombinant factor VIIa (NovoSeven®) as a hemostatic agent
|
Hedner, Ulla
|
|
2001
|
38 |
S12 |
p. 43-47
5 p.
|
article
|
| 6 |
Recombinant factor VIIa (NovoSeven®) restores deficient coagulation: Experience from an ex vivo model
|
Galán, Ana Maria
|
|
2001
|
38 |
S12 |
p. 10-14
5 p.
|
article
|
| 7 |
The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis
|
Hoffman, Maureane
|
|
2001
|
38 |
S12 |
p. 6-9
4 p.
|
article
|
| 8 |
The role of platelets in decrypting monocyte tissue factor
|
Østerud, Bjarne
|
|
2001
|
38 |
S12 |
p. 2-5
4 p.
|
article
|
| 9 |
Tissue factor in experimental acute lung injury
|
Welty-Wolf, Karen E
|
|
2001
|
38 |
S12 |
p. 35-38
4 p.
|
article
|
| 10 |
Treatment of bleeding and thrombotic disorders: Introduction
|
Roberts, Harold R
|
|
2001
|
38 |
S12 |
p. 1-
1 p.
|
article
|
| 11 |
Use of recombinant factor VIIa (NovoSeven®) in patients with Glanzmann thrombasthenia
|
Poon, Man-Chiu
|
|
2001
|
38 |
S12 |
p. 21-25
5 p.
|
article
|
Journal description